Antithymocyte Globulin for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation

被引：10
|
作者：
Mohty, Mohamad [1 ]
Malard, Florent
机构：
[1] Hop St Antoine, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 36期
关键词：
MATCHED UNRELATED DONORS; ANTI-THYMOCYTE GLOBULIN; OPEN-LABEL; HEMATOLOGICAL MALIGNANCIES; PHASE-3; TRIAL; MULTICENTER; MARROW; PREVENTION; MORTALITY; OUTCOMES;
D O I：
10.1200/JCO.2017.76.0512
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：3993 / +
页数：4
相关论文
共 50 条
  • [1] Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation
    Bryant, Adam
    Mallick, Ranjeeta
    Huebsch, Lothar
    Allan, David
    Atkins, Harold
    Anstee, Grizel
    Sabloff, Mitchell
    Scrivens, Nicholas
    Maze, Dawn
    Bredeson, Chris
    Kekre, Natasha
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (12) : 2096 - 2101
  • [2] Severe Hyperglycemia Immediately After Allogeneic Hematopoietic Stem-Cell Transplantation is Predictive of Acute Graft-Versus-Host Disease
    Efrem Gebremedhin
    Carolyn E. Behrendt
    Ryotaro Nakamura
    Pablo Parker
    Behrouz Salehian
    Inflammation, 2013, 36 : 177 - 185
  • [3] Graft-versus-host disease during allogeneic haematopoietic stem-cell transplantation
    Krieg, A
    Zander, A
    Kuehnl, P
    Eiermann, T
    GENES AND IMMUNITY, 2004, 5 : S26 - S26
  • [4] Severe Hyperglycemia Immediately After Allogeneic Hematopoietic Stem-Cell Transplantation is Predictive of Acute Graft-Versus-Host Disease
    Gebremedhin, Efrem
    Behrendt, Carolyn E.
    Nakamura, Ryotaro
    Parker, Pablo
    Salehian, Behrouz
    INFLAMMATION, 2013, 36 (01) : 177 - 185
  • [5] Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Nassar, Amr
    Elgohary, Ghada
    Elhassan, Tusneem
    Nurgat, Zubeir
    Mohamed, Said Y.
    Aljurf, Mahmoud
    JOURNAL OF TRANSPLANTATION, 2014, 2014
  • [6] Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Chen, Yi-Bin
    Shah, Nirav N.
    Renteria, Anne S.
    Cutler, Corey
    Jansson, Johan
    Akbari, Mona
    Chen, Chunlin
    Quadri, Syed
    Parfionovas, Andrejus
    Devine, Steven M.
    BLOOD ADVANCES, 2019, 3 (23) : 4136 - 4146
  • [7] Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Omer, Aazim K.
    Weisdorf, Daniel J.
    Lazaryan, Aleksandr
    Shanley, Ryan
    Blazar, Bruce R.
    MacMillan, Margaret L.
    Brunstein, Claudio
    Bejanyan, Nelli
    Arora, Mukta
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (05) : 879 - 883
  • [8] Acute graft-versus-host disease following hematopoietic stem-cell transplantation
    Hu, Stephanie W.
    Cotliar, Jonathan
    DERMATOLOGIC THERAPY, 2011, 24 (04) : 411 - 423
  • [9] A PROSPECTIVE PILOT STUDY OF GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS WITH POSTBIOTICS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Won, Jong-Ho
    Yoon, Seug Yun
    Jeong, Sun Young
    Lee, Min-Young
    Kim, Kyoung Ha
    Lee, Namsu
    BONE MARROW TRANSPLANTATION, 2024, 59 : 337 - 338
  • [10] Antithymocyte globulin for acute-graft-versus-host-disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation: a systematic review
    A Kumar
    A R Mhaskar
    T Reljic
    R S Mhaskar
    M A Kharfan-Dabaja
    C Anasetti
    M Mohty
    B Djulbegovic
    Leukemia, 2012, 26 : 582 - 588
12345